Overpaying for anything is a bad idea. But it’s an especially bad thing when it comes to investing in the stock market.
James Montier at GMO correctly observes:
“Over the years I’ve witnessed many attempts by the practitioners of this most dark art to justify why tried and tested measures of valuation are no longer meaningful,
…